Indeed, Lrrc32 specific gene amplification was observed in human breast cancer [28] and primary and metastatic neck lymph nodes in oral squamous cell carcinoma [22]; moreover, in prostate cancer, Lrrc32 amplification rate increases with the decrease of hormone sensitivity [23]. The gene discussed is LRRC32; the disease is Familial prostate cancer.